Genetic methylation test - What a gene test can tell you about your brain health
- Alissa Powell
- Jun 15
- 10 min read
Why methylation matters (even if you’ve never heard of it)
Most people have never heard the word methylation, yet it quietly affects many processes that shape how you think, feel and recover. If you struggle with persistent brain fog, low mood, poor concentration, unexplained fatigue or slow recovery after illness, you may have wondered whether there’s a deeper biochemical reason. Methylation is one of those biochemical systems that links nutrition, detoxification, neurotransmitters and gene regulation. A genetic methylation test looks for common variations in the genes that support these pathways. For some people, knowing their genetic tendencies can clarify why they respond differently to certain foods, supplements or stressors - and it can point to safer, more personalised strategies to support brain (and systemic) health.
This article explains methylation, what a genetic methylation test can tell you, how results are interpreted in a clinical context, and practical next steps if you’re considering testing.
Key Takeaways:
|
Table of Contents
What is methylation?
Methylation is a basic chemical process your body uses to keep many systems running smoothly. It works by adding a tiny chemical group (a ‘methyl group’ containing one carbon and three hydrogens) to molecules inside your cells, which helps control how genes behave, how brain chemicals are made and cleared, and how your body processes toxins and repairs itself. Methylation also supports important compounds like SAMe (a universal methyl donor) and glutathione (a key antioxidant), which play roles in mood, energy, inflammation and overall brain resilience. When methylation is well supported, your brain tends to function more clearly; when it’s under strain from genetics, stress, nutrient gaps or illness, people may notice issues like brain fog, low mood or fatigue.
Why methylation matters for brain health
smoothly. When there are genetic tendencies or environmental pressures (poor diet, chronic stress, inflammation, medication effects), these systems can become less efficient. That may show up as:
Cognitive fatigue and brain fog - difficulty concentrating, slower thinking.
Mood instability - low mood, anxiety or emotional reactivity.
Poor recovery and fatigue - slower healing, persistent tiredness.
Nutrient handling issues - low B12 or folate despite supplementation and good diet; raised homocysteine.
Importantly, genetics are only part of the story. Lifestyle, diet, gut health, sleep and inflammation all interact with methylation. Genetic testing can highlight predispositions, but it rarely provides a single, definitive answer, which is why working with a certified nutritional therapist can help make sense of it all.
Which genes are commonly tested - and what they do
Genetic methylation panels vary from a single MTHFR SNP to broad panels covering many related genes.
Commonly included genes:
MTHFR (methylenetetrahydrofolate reductase)
What it does MTHFR is an enzyme that helps convert dietary folate into its active form, 5‑MTHF, which the body uses in many one‑carbon reactions - including the re-methylation of homocysteine to methionine and the production of methyl groups used across the brain.
How variants may affect brain health Common variants (for example C677T and A1298C) can reduce enzyme efficiency to varying degrees. That can make it harder for some people to generate active folate from supplements or food, which in certain situations may contribute to raised homocysteine or subtle changes in neurotransmitter synthesis - factors that have been linked with cognitive fog, low mood or poor mental stamina.
What clinicians typically check Serum or red‑cell folate, active B12 (holotranscobalamin), homocysteine and, where indicated, methylmalonic acid. Medication history (for example long‑term anticonvulsants, methotrexate or proton pump inhibitors) and pregnancy planning are also relevant.
Practical considerations If a variant is present, clinicians usually focus on confirming nutrient status first rather than acting on genotype alone. Dietary folate, appropriate forms of folate and monitoring of homocysteine are common next steps under professional guidance.
MTR / MTRR (methionine synthase and its regulator)
What they do MTR (methionine synthase) uses vitamin B12 to convert homocysteine back into methionine. MTRR (methionine synthase reductase) helps regenerate the active B12 cofactor so MTR can keep working. Together they support the B12‑dependent arm of re-methylation.
How variants may affect brain health Variants in MTR or MTRR can subtly reduce the efficiency of B12‑dependent re-methylation. If this pathway is less efficient, homocysteine may rise and availability of methionine and SAMe (important for brain methylation reactions) can be affected - potentially influencing mood, energy and cognitive resilience, especially if B12 status is low.
What clinicians typically check Serum B12, active B12 (holotranscobalamin), methylmalonic acid (to detect functional B12 deficiency) and homocysteine. A medication and absorption review is important because some drugs and gut conditions affect B12.
Practical considerations Addressing B12 status and gut absorption is usually the priority. Genetic findings are interpreted alongside these objective markers before any changes to supplements are made.
COMT (catechol‑O‑methyltransferase)
What it does COMT is an enzyme that uses methyl groups to break down catecholamines - dopamine, noradrenaline and adrenaline - and other catechol compounds in the brain.
How variants may affect brain health COMT variants change how quickly catecholamines are cleared. Some variants are linked with faster breakdown (which can affect motivation and focus), others with slower breakdown (which can increase sensitivity to stress or stimulants). These differences can influence attention, emotional regulation, sleep and how someone responds to stress or certain supplements.
What clinicians typically check There is no single blood test for COMT activity. Clinicians interpret COMT variants in the context of symptom patterns (for example anxiety, poor stress tolerance, sleep problems), medication and supplement use, and overall methylation and nutrient status.
Practical considerations Management tends to be symptom‑led: stress‑reduction, consistent sleep, pacing of stimulatory supplements and personalised nutritional support rather than blanket protocols.
CBS (cystathionine beta‑synthase)
What it does CBS is the first enzyme in the transsulphuration pathway, converting homocysteine into cystathionine, which eventually contributes to cysteine and glutathione - key components of antioxidant defence and sulphur metabolism.
How variants may affect brain health Some CBS variants are described as increasing flux through the transsulphuration pathway, which can change how sulphur compounds are handled. Clinically this is sometimes considered when people report sulphur sensitivity (for example to garlic or certain supplements) or have unusual responses to sulphur‑containing nutrients. Effects on glutathione and oxidative stress may be relevant to neuroinflammation and fatigue, but evidence is mixed and context matters.
What clinicians typically check Homocysteine, and where available cysteine or glutathione markers, plus liver function and a careful symptom history about sulphur tolerance. Gut microbiome factors can also influence sulphur metabolism and are considered.
Practical considerations If sulphur sensitivity is suspected, clinicians introduce sulphur‑rich foods or supplements cautiously and focus on supporting antioxidant systems and gut health rather than making assumptions from genotype alone.
BHMT (betaine‑homocysteine methyltransferase)
What it does BHMT provides an alternative, folate‑independent route to re-methylate homocysteine using betaine (derived from choline). This pathway is especially active in the liver and kidneys and helps maintain methionine and methyl group supply.
How variants may affect brain health Variants in BHMT can shift reliance between methylation pathways. In some people, stronger BHMT activity may compensate when folate‑dependent re-methylation is less efficient; in others, differences may increase choline requirements or alter homocysteine handling. These shifts can influence one‑carbon metabolism and, indirectly, brain methylation capacity.
What clinicians typically check Homocysteine and dietary choline intake (for example eggs, liver, soy, cruciferous vegetables). Liver health and broader metabolic context are important because BHMT activity is liver‑centred.
Practical considerations Clinicians consider dietary choline and liver support as part of a broader plan. Introducing concentrated betaine supplements is done cautiously and only with clinical oversight, particularly in complex cases or pregnancy.
A broader panel may include genes related to folate transport, B12 handling, and other methylation cofactors. Each variant may slightly alter enzyme efficiency -but the clinical impact depends on the whole picture.
What a genetic methylation test shows - and what it doesn’t
What it shows
Which common variants (SNPs) you carry in methylation-related genes.
Potential tendencies in folate/B12 handling, homocysteine metabolism and neurotransmitter processing.
What it does not show
Your current biochemical status (you need blood tests for that).
That a variant will definitely cause symptoms - many people with the same variants are well. Genotype indicates tendency, not destiny.
A complete explanation for complex symptoms on its own.
Why interpretation matters
A responsible clinician will combine genetic results with blood tests, medication review and clinical history. That approach reduces the risk of unnecessary or inappropriate interventions.
Choosing a methylation test
When selecting a provider, consider:
Clinical-grade reporting with clear interpretation rather than raw genotype lists.
Access to practitioner support so a qualified clinician can review results.
Laboratory accreditation and transparent methodology.
Panel scope - single-gene tests are cheaper but limited; broader panels require more nuanced interpretation.
If you’re unsure, work with a trained clinician who will recommend the best test.
Frequently Asked Questions
What is a methylation gene test?
A methylation gene test is a targeted DNA test that looks for common variants in genes involved in methylation pathways. It identifies genetic tendencies that may influence folate and B12 metabolism, homocysteine handling and neurotransmitter processing.
What are some common reasons people test methylation genes?
Brain fog; poor concentration; low mood or anxiety; persistent fatigue; recurrent nutrient deficiencies; fertility or pregnancy planning; family history of cardiovascular or neurological issues.
What does a genetic methylation test reveal?
Presence of common gene variants (SNPs – pronounced ‘snips’) in genes such as MTHFR, MTRR, COMT, CBS, BHMT that may influence folate/B12 handling, homocysteine metabolism and neurotransmitter processing.
Will a methylation test tell me why I have brain fog?
Not by itself. A test can highlight predispositions that may contribute to cognitive symptoms, but a full clinical assessment and blood tests are usually needed to identify actionable causes.
Is MTHFR testing necessary?
MTHFR is commonly tested because variants are frequent and can affect folate metabolism. However, MTHFR is only one part of the methylation system. Testing is most useful when results will change management and are interpreted alongside clinical data.
Can methylation testing guide supplement choices?
It can inform which nutrients to monitor and which forms of folate or B12 may be preferable. Clinical oversight is important to avoid inappropriate dosing or interactions, especially in pregnancy or when taking medications.
How long until I see benefits from changes guided by testing?
Responses vary. Some people notice improvements in weeks; others require months and ongoing monitoring. Objective markers such as homocysteine can help track biochemical response.
Conclusion and next steps
Genetic methylation testing can be a helpful piece of the puzzle for people seeking deeper answers about brain fog, mood instability and fatigue. Its greatest value comes when genetic data are integrated with clinical history, targeted blood tests and personalised nutritional strategies. If you’re considering testing, a careful, evidence-informed approach reduces risk and increases the chance of meaningful, measurable benefit.
If you’d like a clinical review of your symptoms and to discuss whether methylation testing is appropriate for you, book a discovery call to explore a personalised plan and interpretation. We’ll help you choose the best test, make sense of the results, and turn insights into an actionable plan tailored to you.
About the Author
Alissa Powell, Nutritional Therapist | Certified LifecodeGx Nutrigenomics Practitioner
Alissa is a Nutritional Therapist specialising in nervous‑system regulation and brain health. She trained at the College of Naturopathic Medicine (CNM) and developed her clinical skills in functional medicine settings, working with people facing complex, chronic and often undiagnosed conditions. Alissa combines evidence‑led nutritional strategies with breathwork (certified Buteyko instructor) and movement‑based practices (Qigong, Tai Chi) to support resilience, energy and cognitive clarity.
Special interests: brain fog, ADHD support, burnout and chronic stress, Long COVID, CFS/ME, anxiety, autoimmunity and gut‑brain links. Clinical approach: personalised, pragmatic and measurement‑focused - she integrates genetic (LifecodeGx) and blood‑test data with lifestyle and medication review, and works closely with GPs and specialists for complex cases. Find out more about Alissa and book a discovery call to work with her.
References
Smith, A.D., Refsum, H., Bottiglieri, T., Fenech, M., Hooshmand, B., McCaddon, A., Miller, J.W., Rosenberg, I.H. & Obeid, R. (2018) Homocysteine and Dementia: An International Consensus Statement. Journal of Alzheimer’s Disease, 62(2), pp.561–570. Available at: https://doi.org/10.3233/JAD-171042.
Lab Tests Online UK (no date) MTHFR. Lab Tests Online‑UK. Available at: https://www.labtestsonline.org.uk/ .
RACGP / GP resource (MyGPNotes) (2026) GP resource – MTHFR gene testing. First Do No Harm: Choosing Wisely. Available at: https://www.mygpnotes.com/wp-content/uploads/2026/05/GP-resource-MTHFR-gene-testing.pdf.
NHS Tayside (no date) MTHFR associated Folate Disorders. NHS Scotland. Available at: https://www.nhstayside.scot.nhs.uk/ (accessed 11 June 2026).Morris, M.S. (2019) Hyperhomocysteinemia and risk of incident cognitive outcomes: an updated dose‑response meta‑analysis of prospective cohort studies. Ageing Research Reviews, 51, pp.55–66.
Dickinson, D. & Elvevåg, B. (2009) Genes, Cognition and Brain through a COMT Lens. Neuroscience, 164(1), pp.72–87.
Schacht, J.P. (2016) COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review. Pharmacogenomics Journal, 16, pp.430–438.
Ereño‑Orbea, M., Majtan, T., Oyenarte, I., Kraus, J.P. & Martínez‑Cruz, L.A. (2013) Structural basis of regulation and oligomerization of human cystathionine β‑synthase. Proceedings of the National Academy of Sciences USA, 110(40), E3790–E3799.
Niu, W.‑N., Yadav, P.K., Adamec, J. & Banerjee, R. (2015) S‑Glutathionylation Enhances Human Cystathionine β‑Synthase Activity Under Oxidative Stress Conditions. Antioxidants & Redox Signaling, 22(5), pp.350–361.
Pajares, M.A. & Pérez‑Sala, D. (2006) Betaine homocysteine methyltransferase: just a regulator of homocysteine metabolism? Cellular and Molecular Life Sciences, 63(23), pp.2792–2803.
Han, H.‑K. et al. (2024) Regulation of Betaine Homocysteine Methyltransferase by Liver Receptor Homolog‑1 in the Methionine Cycle. Molecular and Cellular Biology, 44(6), pp.245–258.
Lifecode Gx Methylation Report - Lifecode Gx. Lifecode Gx website. Available at: https://lifecodegx.com/methylation-report (accessed 11 June 2026).
Comments